BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33051990)

  • 21. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease.
    Wetherill PE; Landry ML; Alcabes P; Friedland G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):33-7. PubMed ID: 8624758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience.
    Cui J; Yan W; Xie H; Xu S; Wang Q; Zhang W; Ni A
    PLoS One; 2019; 14(8):e0221793. PubMed ID: 31461496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence.
    Landry ML; Ferguson D; Stevens-Ayers T; de Jonge MW; Boeckh M
    J Clin Microbiol; 1996 May; 34(5):1337-9. PubMed ID: 8727936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients.
    Schirm J; Kooistra A; van Son WJ; van der Bij W; Verschuuren E; Sprenger HG; Limburg PC; The TH
    J Clin Virol; 1999 Dec; 14(3):153-65. PubMed ID: 10614852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus infection during immunosuppressive therapy for diffuse parenchymal lung disease.
    Arai T; Inoue Y; Tachibana K; Tsuyuguchi K; Nishiyama A; Sugimoto C; Sasaki Y; Kagawa T; Matsuda Y; Hayashi S
    Respirology; 2013 Jan; 18(1):117-24. PubMed ID: 22978348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients.
    Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A
    J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
    Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
    Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
    Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
    Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients.
    Podzamczer D; Ferrer E; García A; Ramón JM; Niubó J; Santín M; Rufí G; Pérez JL; Martín R; Gudiol F
    Scand J Infect Dis; 1997; 29(3):223-7. PubMed ID: 9255879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease.
    Suga K; Nishiwaki A; Nakamura T; Kagami SI
    Rheumatol Int; 2023 Jun; 43(6):1093-1099. PubMed ID: 36042051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.
    Tan BH; Chlebicka NL; Low JG; Chong TY; Chan KP; Goh YT
    Transpl Infect Dis; 2008 Oct; 10(5):325-32. PubMed ID: 18627578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the cytomegalovirus (CMV) antigenemia assay for the rapid diagnosis of primary CMV infection in hospitalized adults.
    Lesprit P; Scieux C; Lemann M; Carbonelle E; Modaï J; Molina JM
    Clin Infect Dis; 1998 Mar; 26(3):646-50. PubMed ID: 9524838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cytomegalovirus-antigenemia assay in the diagnosis of posttransplant cytomegalovirus infection.
    Murray BM; Brentjens J; Amsterdam D; Myers J; Gray V; Pawlowski I; Schewegler K; Singh JP; Venuto RC
    J Am Soc Nephrol; 1994 Feb; 4(8):1615-22. PubMed ID: 8025235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical importance of cytomegalovirus antigenemia for intrauterine cytomegalovirus infection.
    Kaneko M; Sameshima H; Ikenoue T; Kusumoto K; Minematsu T
    Pediatr Int; 2009 Feb; 51(1):1-4. PubMed ID: 19371269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Predictive Model Using Endoscopic Features for Gastric Cytomegalovirus Infection in Renal Transplant Patients.
    Yeo SJ; Kwon KT; Kim ES; Jung MK; Kim SK; Lee HS; Lee JS; Lee SW; Lee YJ; Kwak SG; Han S
    Transplantation; 2019 May; 103(5):998-1004. PubMed ID: 30507742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cytomegalovirus antigenemia assay: a plea for standardization.
    The TH; van den Berg AP; Harmsen MC; van der Bij W; van Son WJ
    Scand J Infect Dis Suppl; 1995; 99():25-9. PubMed ID: 8668937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.